NEW

Aerobiotix Announces FDA 510(k) Clearance of Medical Ultraviolet Air Filtration System

Aerobiotix Inc., a manufacturer of air treatment devices for hospitals and health care, has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Aerocure-MD medical air purification system.

AAAHC Releases Updated Toolkit Outlining Ambulatory Procedure Considerations for Obese Patients

To help ASCs implement necessary precautions and prevent negative outcomes for obese patients, the Accreditation Association for Ambulatory Health Care (AAAHC) has published a fully revised Ambulatory Procedure Considerations for Obese Patients Toolkit.

FDA Updates Information on Respirator Decontamination Systems

The U.S. Food and Drug Administration (FDA) is reissuing the Emergency Use Authorizations for decontamination systems that are authorized to decontaminate compatible N95 respirators for use by healthcare personnel (HCP) to prevent exposure to pathogenic biological...

First Patient Treated in Clinical Trial of BCL System

CairnSurgical, Inc., an innovator striving to make breast cancer surgery more precise, announced that the first patient has been treated in its U.S. pivotal trial of the Breast Cancer Locator (BCL) System at Massachusetts General Hospital.

Tru-D SmartUVC to Exhibit at AORN Expo

A leader in the UV disinfection industry, Tru-D SmartUVC will exhibit its patented “smart” technology at the Association for Perioperative Registered Nurses’ (AORN) Surgical Conference and Expo 2016 in Boston, Massachusetts April 2-4, 2017 at booth #1748. In addition to exhibiting and attending the AORN Surgical Conference, Tru-D has proudly joined the 2500 Club as a sponsor of the AORN Foundation. The industry standard in advocating for excellence in perioperative practice and health care, AORN provides perioperative nurses with education and resources for safe clinical practice and professional development.

“Hospital-acquired infections including surgical-site infections continue to be top-of-mind for patient safety and care in health care facilities,” said Chuck Dunn, president and CEO of Tru-D SmartUVC. “Tru-D has been validated to reduce the risk of infection by the only randomized clinical trial on UV disinfection, and we are excited to share the study’s results and our technology with attendees of AORN.”

The recently-published Benefits of Enhanced Terminal Room-Disinfection (BETR-D) study which was funded by the Centers for Disease Control and Prevention Epicenter Program and conducted across the Duke Infection Control Outreach Network showed that Tru-D is able to reduce the risk of infection of C. diff, MRSA, VRE and Acinetobacter among patients admitted to the same room by a cumulative 30 percent. Conducted throughout nine hospitals for a total of 600,000 room stays and more than 22,000 Tru-D cycles completed, the BETR-D randomized clinical trial is the most comprehensive study on UV disinfection to date.

“Tru-D is the only ‘smart’ UV disinfection robot with patented Sensor360 technology that can guarantee a baseline of disinfection and thorough operating room disinfection with every cycle,” said Dunn. “Tru-D’s basis of scientific evidence and widespread adoption throughout prestigious hospital systems continues to drive market acceptance of UV disinfection technology.”

Tru-D is deployed in hospital and operating rooms after an environmental services member cleans the area with traditional cleaning methods. Using chemical-free UVC energy, Tru-D operates from a single position and administers a single cycle of UV light, easily integrating into a hospital’s existing workflow with minimal labor impact. Through the use of its patented Sensor360 technology, Tru-D analyzes the space including size, shape and contents, to deliver a precise, lethal dose of UV light, achieving significant pathogen reduction in the room. While the cycle is being performed, operators are free to tend to other tasks and are alerted via audio and/or text message when disinfection is complete.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X